The prognosis of dementia with Lewy bodies

@article{Mueller2017ThePO,
  title={The prognosis of dementia with Lewy bodies},
  author={C. Mueller and C. Ballard and A. Corbett and D. Aarsland},
  journal={The Lancet Neurology},
  year={2017},
  volume={16},
  pages={390-398}
}
Dementia with Lewy bodies is the second most common form of neurodegenerative dementia, yet scarce evidence is available about its prognosis and natural history, which are crucial to inform clinical practice and research. Patients with dementia with Lewy bodies might have a less favourable prognosis, with accelerated cognitive decline, shorter lifespan, and increased admission to residential care than patients with Alzheimer's disease. Health-care costs and, importantly, caregiver burden, are… Expand
Medication Use and Prognosis of Alzheimer's Disease and Lewy Body Dementia
Background: There is no curative treatment available for the cause of dementia, and few drugs are approved for symptomatic treatment. In addition, knowledge about prognosis related to hospitalizationExpand
[Dementia with Lewy bodies].
TLDR
Dementia with Lewy bodies is characterized histopathologically by the deposition of α-synuclein in inclusion bodies and therapy concepts include treatment of loss of motor and cognitive performance as well as psychological and behavioral symptoms. Expand
Review: Clinical, neuropathological and genetic features of Lewy body dementias
TLDR
The aim of this article is to review the main clinical, neuropathological and genetic aspects of dementia with Lewy bodies and Parkinson's disease dementia, particularly relevant as future management for these two conditions may differ. Expand
Dementia with Lewy bodies and Parkinson’s disease-dementia: current concepts and controversies
TLDR
Both DLB and PDD show heterogeneous pathology and neurochemistry, suggesting that they share important common underlying molecular pathogenesis with AD and other proteinopathies, and there remains a pressing need to differentiate them more clearly. Expand
Challenges in Predicting Cognitive Decline in Dementia with Lewy Bodies
TLDR
Assessment tools measuring cognitive domains predominantly affected in DLB need to be more consistently used in longitudinal studies and clinical practice, as well as concurrent measures of fluctuations in cognition, to enable more accurate monitoring and prediction of cognitive decline inDLB. Expand
Clinical Presentation, Diagnostic Features, and Mortality in Dementia with Lewy Bodies.
TLDR
Examining in detail, symptom patterns at presentation and their association with outcomes, including mortality, in a large naturalistic DLB cohort from a secondary care sample to establish initial presentation, neuropsychological profile, and mortality is examined. Expand
Relative survival in patients with dementia with Lewy bodies and Parkinson’s disease dementia
TLDR
The mortality is over three-times higher in patients diagnosed with dementia with Lewy bodies and Parkinson’s disease dementia during a ten-year follow-up, compared to persons in the general population. Expand
Mortality in dementia with Lewy bodies compared with Alzheimer’s dementia: a retrospective naturalistic cohort study
TLDR
Survival from first presentation with cognitive impairment was markedly shorter in DLB compared with AD, independent of age, sex, physical comorbidity or antipsychotic prescribing, which adds to existing evidence for poorer survival for DLB versus AD. Expand
On Gaps of Clinical Diagnosis of Dementia Subtypes: A Study of Alzheimer's Disease and Lewy Body Disease
TLDR
Clinical diagnosis of AD, LBD and AD+LBD are inaccurate and harbor significant disparities based on race and sex, and "No cognitive impairment", "Undecided" and "primary progressive aphasia or behavioral variant frontotemporal dementia" were the leading primary etiologic clinical diagnosis. Expand
Neurodegenerative Diseases: Lewy Body Dementia
TLDR
Lewy body disease (LBD) is a chronic progressive neuropsychiatric disorder characterized by parkinsonism with or without dementia, and staging of the lesions and regions involves results in four stages. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 79 REFERENCES
Lewy body dementias
TLDR
The most pertinent progress from the past 10 years is summarized, outlining some of the challenges for the future, which will require refinement of diagnosis and clarification of the pathogenesis, leading to disease-modifying treatments. Expand
Lewy body dementia: the impact on patients and caregivers
Lewy body dementia (LBD) is the second most common neurodegenerative dementia in older adults, yet there remains a delay in diagnosis that limits healthcare providers’ ability to maximize therapeuticExpand
Predictors of Survival in Dementia with Lewy Bodies and Parkinson Dementia
TLDR
Retrospective analysis of 243 autopsy-confirmed cases of dementia with Lewy bodies (DLB) and Parkinson disease with dementia (PDD) showed an average age at symptom onset of 67 years and a median survival of 5 years from symptom onset; initial parkinsonism with delayed dementia significantly improved survival. Expand
Cognitive decline in dementia with Lewy bodies: a 5-year prospective cohort study
TLDR
The findings show that from the mild dementia stage, patients with DLB have a more rapid cognitive decline than in AD, crucial for planning clinical trials and enabling health economic modelling. Expand
Lewy bodies and progressive dementia: a critical review and meta-analysis.
  • S. P. Cercy, F. Bylsma
  • Psychology, Medicine
  • Journal of the International Neuropsychological Society : JINS
  • 1997
TLDR
The cognitive profile of LBD patients, and the relationships among LBD, AD, and PD remain unclear due to methodological limitations and the paucity of studies comparing the groups directly. Expand
Diagnosis and management of dementia with Lewy bodies
TLDR
The authors propose a new scheme for the pathologic assessment of LBs and Lewy neurites (LN) using alpha-synuclein immunohistochemistry and semiquantitative grading of lesion density, with the pattern of regional involvement being more important than total LB count. Expand
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB)
TLDR
This work identified progressive disabling mental impairment progressing to dementia as the central feature of DLB, and identified optimal staining methods for each of these and devised a protocol for the evaluation of cortical LB frequency based on a brain sampling procedure consistent with CERAD. Expand
Cognitive decline is faster in Lewy body variant than in Alzheimer's disease
TLDR
This study demonstrates that LBV is characterized by a faster cognitive decline and accelerated mortality compared with AD. Expand
Cognitive decline in patients with Alzheimer's disease, vascular dementia and senile dementia of Lewy body type.
TLDR
Patients with DSM-III-R dementia were assessed with a standardized battery which included the Geriatric Mental State Schedule, the History and Aetiology schedule, the Secondary Dementia Schedule and the CAMCOG. Expand
Operational criteria for senile dementia of Lewy body type (SDLT).
Recent reports have suggested that brain stem and cortical Lewy body formation may identify a neurodegenerative disorder in elderly demented individuals which accounts for up to 20% of cases ofExpand
...
1
2
3
4
5
...